Biotech Values

[WorstLuck]

I’m personally disappointed in how lackluster or outright bad RVNC’s share price has performed AFTER they got FDA approval. It’s not what I expected.

Sell the launch is the norm for a smaller bio on it's first approval. It's easy to find examples. This launch is already short of expectation. On the plus side, maybe they have reset the bar low enough to actually outperform (resetting of expectations.) Remains to be seen.